1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl,
Halfan,
halofantrine,
halofantrine hydrochloride,
WR 171,699,
WR 171669,
WR-171,669,
WR-171699,
HALOFANTRINE HYDROCHLORIDE,
Halfan,
36167-63-2,
Halofantrino [Spanish],
(+-)-Halofantrine hydrochloride,
Halofantrine HCl,
WR 171669,
Halofantrine Hydrochloride [USAN],
WR-171,669,
EINECS 252-895-4,
UNII-2B7ENL644K,
C26H30Cl2F3NO.HCl,
WR-171669,
2B7ENL644K,
NCGC00016833-01,
1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl,
1-(1,3-Dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol hydrochloride,
9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride,
DSSTox_CID_25464,
DSSTox_RID_80895,
DSSTox_GSID_45464,
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride,
W-106636,
Halofantrine hydrochloride (USAN),
Halofantrino,
MLS002154111,
1,3-Dichloro-a-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride,
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride,
3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride,
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride,
CAS-36167-63-2,
SMR001233418,
1,3-DICHLORO-ALPHA-[2-(DIBUTYLAMINO)ETHYL]-6-(TRIFLUOROMETHYL)-9-PHENANTHRENEMETHANOL HYDROCHLORIDE,
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride,
Halfan (TN),
SKF 102886,
Halofantrine hydrochlorid,
WR-171699,
AC1L1XMK,
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride,
WR 171,699,
HALFAN HYDROCHLORIDE,
SCHEMBL466895,
(-)-Halofantrine hydrochloride,
CHEMBL1200901,
DTXSID0045464,
CTK8G0127,
HY-A0148A,
Halofantrine hydrochloride, (-)-,
HMS1571O03,
Tox21_110637,
MFCD00879136,
AKOS030254762,
Tox21_110637_1,
API0002884,
CCG-221031,
YF10095,
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl,
SK&F-102866,
NCGC00179250-03,
LS-102675,
CS-0031225,
FT-0082696,
FT-0600399,
Z3682,
D02485,
167H632,
C-34958,
Halofantrine hydrochloride, >=98% (HPLC), solid,
SR-01000841216,
SR-01000841216-2,
Halofantrine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
1-[1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol hydrochloride,
3-DIBUTYLAMINO-1-(1,3-DICHLORO-6-TRIFLUOROMETHYL-PHENANTHREN-9-YL)-PROPAN-1-OL HCL,
66051-64-7,
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride, (-)-,
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-,hydrochloride,
Halofantrine,
UNII-H77DL0Y630,
C26H30Cl2F3NO.ClH,
H77DL0Y630,
CID37392,
C26-H30-Cl2-F3-N-O.Cl-H,
C023768,
69756-53-2,
106927-11-1,
1,3-dichloro-alpha-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride,